TrimRx charges a single monthly medication price with no separate membership fee. Published starting rates have run near $199 for compounded semaglutide and near $349 for compounded tirzepatide, held flat as the dose rises. The consult, supplies, and shipping are bundled. Laboratory testing is not, and insurance is not billed. Rates move with promotions, so the current order page is the only reliable figure.
What the single monthly figure actually covers
The bundle is the point of this pricing model. One charge covers the prescriber review, the compounded medication itself, injection supplies, delivery, and continued access to the prescriber through the patient portal. There is no enrollment charge and no separate consult fee sitting behind the advertised number.
That structure is worth understanding because it is not the market default. Several cash-pay competitors split the same services into a recurring membership plus a medication charge, and a $99 membership alongside a lower medication price can land above a bundled competitor once both lines are added. Comparing one bundled figure against one unbundled figure produces a meaningless result.
Flat pricing versus dose-tiered pricing
Every GLP-1 regimen escalates. Approved products for weight management begin below their maintenance strength and step up over months, and compounded prescribing follows the same general logic under the prescriber’s direction. Many compounded platforms price by strength, so the monthly cost climbs alongside the dose.
Flat pricing removes that escalator. The month-one price is the month-twelve price regardless of where the prescriber lands. On a treatment that is measured in years rather than weeks, that is the difference that shows up in an annual total, and it is the strongest argument in favor of this particular program.
That flat-versus-tiered split is the single most useful thing to check when lining up cash-pay options against one another. Services such as Ro, Hims and Hers, and Henry Meds each handle dose pricing differently, and HealthRX publishes the price of its GLP-1 medications at each strength so the month-twelve figure is visible rather than implied. Set against the brand self-pay routes at LillyDirect and NovoCare, which charge per fill for approved products, the compounded programs win on headline price but ask the shopper to read the dose ladder closely.
| Cost line | Bundled flat-rate approach | Common alternative approach | What to verify |
|---|---|---|---|
| Medication | One monthly price per molecule | Price rises at each strength | The quoted cost at the highest strength |
| Membership | None charged separately | Recurring platform or coaching fee | Whether the fee continues if medication pauses |
| Consult | Included in the monthly figure | Separate initial and follow-up fees | Cost of an unscheduled prescriber message |
| Labs | Not routinely included | Sometimes included, sometimes required | Who orders them and who pays |
| Shipping and supplies | Bundled | Occasionally billed per shipment | Cost of a reship after a delivery failure |
| Payment method | Cash pay, HSA and FSA cards often accepted | Same, insurance rarely billed | Whether a superbill is available |
Laboratory testing is the line most people forget
Baseline and follow-up bloodwork is not part of the advertised price here, and practice across the category is inconsistent. Some platforms include a panel, some require results you obtain elsewhere, and some request nothing. Clinical practice guidelines for obesity pharmacotherapy treat monitoring and attention to metabolic comorbidities as part of ongoing care rather than an optional extra.
Priced through primary care with insurance, a basic metabolic and lipid panel with an A1c is often a small copay. Paid cash through a direct-to-consumer lab, it is usually a modest one-time cost. Either way it belongs in the annual figure, and a program that never asks for labs has not made the requirement disappear.
Why compounded pricing sits below the brand products
Compounded semaglutide and compounded tirzepatide are not FDA-approved products. The agency has not reviewed those preparations for safety, effectiveness, or manufacturing quality, and it has published specific concerns about unapproved GLP-1 drugs sold for weight loss. That regulatory difference, not a manufacturing discount on the same item, is most of the reason the prices differ.
The brand alternatives have their own self-pay routes. Eli Lilly sells Zepbound vials through LillyDirect and Novo Nordisk sells Wegovy through NovoCare Pharmacy, both well below list price and both dispensing approved products with approved labeling. Medicare drug coverage has historically excluded medications used for weight loss alone, which is a large part of why this cash market exists at all.
Promotional rates decay, and plan length is the catch
Introductory pricing is standard across the sector and frequently attaches to a prepaid multi-month plan. The advertised figure may apply to the first cycle, to a fixed promotional period, or to a longer commitment paid up front. Which of those applies changes the annual total more than the headline number does.
The practical test is whether the price quoted in month one is still the price in month six, and at the strength you are likely to be taking by then. Some cash-pay programs publish that answer outright, and a competing physician-supervised GLP-1 provider maintains a side-by-side breakdown of TrimRx pricing that sets the flat-rate and tiered models against each other. Rival-authored comparisons are a reasonable starting point for the structure, provided every figure is confirmed on each provider’s own current order page before it goes into a budget.
Frequently asked questions
Is there a membership fee on top of the medication price?
No. The advertised monthly figure covers the prescriber review, the medication, supplies, shipping, and portal access, with no separate enrollment or platform charge. That differs from several competitors that bill a recurring membership alongside medication, which is why bundled and unbundled prices cannot be compared line for line.
Does the price rise as the dose increases?
Not under a flat-rate model, which is the main pricing advantage here. Many compounded platforms tier by strength, so their annual cost climbs through the escalation period. Confirm the policy in the current terms, since pricing structures across this market change more often than the advertised entry rate suggests.
Will insurance or a health savings account cover any of it?
Insurance is not billed. Health savings and flexible spending cards are frequently accepted for medical expenses, subject to plan rules and substantiation requirements. Anyone counting on that route should confirm eligibility with the plan administrator rather than assume the transaction will be approved automatically.
Are laboratory tests required, and who pays?
Testing is not bundled into the monthly price. Requirements vary by prescriber and by clinical picture, and where labs are requested the cost falls to the patient through insurance or a cash lab. Budgeting for a baseline panel is sensible even when a program does not require one.
How does the cost compare with brand medication?
Compounded programs generally run well below brand self-pay channels, which reflects a regulatory difference rather than a discount on an identical product. Manufacturer self-pay programs for Zepbound and Wegovy dispense FDA-approved medication at published rates that change periodically and should be checked directly.
